|
ABOUT COMPANY
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes for a period of up to 90 and 180 days. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
|
EARNINGS
Gross Profit (TTM): -17366000
Market Capitalization: 1190775000
Operating Margin (TTM): -3.951
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0.036
Revenue (TTM): 13552000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 3.605
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -1.309
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -115424000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|